First Human Trial Tests Rejuvenation of Aging Eye Cells for Glaucoma
TL;DR Summary
Scientists have begun the first human trial of partial cellular reprogramming to nudge aging eye cells toward a younger state in hopes of regenerating optic nerve neurons to treat glaucoma. The study by Life Biosciences treated the first participant and plans to enroll up to 12 total; this is an early, experimental approach—not a lifespans therapy—with cancer risk as a key concern and no results yet.
- Scientists begin first trial to reverse human aging geekspin
- Experimental gene therapy could open new chapter in aging research, expert says KOMO
- Turning Back the (Biological) Clock theSkimm
- Scientists test first-ever therapy to make human cells young again NewsNation
- First ‘cell rejuvenation’ therapy in humans: Can ageing finally be treated? The Times of India
Reading Insights
Total Reads
1
Unique Readers
6
Time Saved
2 min
vs 3 min read
Condensed
84%
406 → 66 words
Want the full story? Read the original article
Read on geekspin